Accelerating precision probiotic interventions by identifying subgroups of responders through unique biological patterns, aiming to enhance clinical outcomes.
This grant funds early phase clinical trials testing natural products like botanicals, probiotics, and dietary supplements with strong scientific backing for further testing.
Funding for early phase clinical trials of natural products, including botanicals and dietary supplements, to assess impact on target engagement and patient outcomes.
This grant supports mid-phase clinical trials of promising natural products for determining optimal doses/formulations or patient responses, excluding cancer trials.
This grant funds innovative natural history studies to advance medical product development and address unmet needs in rare diseases by generating high-quality, interpretable data.